MITEF Saudi Startup competition announces winners

The nine top-placing participants have now won the right to participate in the 11th MITEF Pan Arab competition.
Updated 05 March 2018

MITEF Saudi Startup competition announces winners

MITEF Saudi Arabia, part of the MITEF global network, has announced the winning teams at the finals of the MITEF Saudi Startup competition.
Participants were competing in three tracks — Startup track, Social Enterprise track, and Ideas track. The winners were:
l In the Startup track, the first prize went to Quantum Solutions, with Avokado taking second prize and Ironix third. Quantum Solutions received SR100,000 ($26,666), with second place receiving SR25,000, and third SR15,000.
l Labayh took first prize in the Social Enterprise track, with Aquaponica second and Blooming Bs third. The first prize winners received SR100,000, SR 25,000 for second place, and third place SR 15,000.
l In the Ideas track, first place was awarded to Duleb, with Cucumber second and Qisma third. The first prize winner received SR20,000, with second and third taking SR15,000 and SR10,000 respectively.
The nine top-placing participants have now won the right to participate in the 11th MITEF Pan Arab competition, which will be held in Oman in April, where the best entrepreneurial ideas from across the region will be showcased.
During her welcoming speech, Sarah Ghaleb, senior general manager of education and entrepreneurship initiatives at Community Jameel, expressed her delight at hosting a selection of national and international guests, investors and entrepreneurs at the final event of the MITEF Saudi Arabia. She said this is the third year a new generation of Saudi entrepreneurs have shown their work in the field of ideas, startups and social enterprise.
The Saudi StartSmart conference was also held as part of the finals event, where distinguished speakers such as Princess Banderi Al-Faisal, chief executive officer of King Khalid Foundation, encouraged local entrepreneurs to keep developing successful social and commercial ideas and projects.
The MITEF Saudi Startup competition is staged by MITEF in partnership with Bab Rizq Jameel (a Community Jameel initiative), Zain Saudi Arabia, and Dulani Business Center.
The closing ceremony was held in Riyadh on March 3. The event was attended by Majid bin Abdullah Al-Qasabi, minister of commerce and investment, as well as prominent Saudi and Arab figures, investors, entrepreneurs, and media representatives.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.